AUXILIUM PHARAMCEUTICALS INC
AUXL
AUXL was delisted on the 29th of January, 2015.
1 hedge funds and large institutions have $3.38M invested in AUXILIUM PHARAMCEUTICALS INC in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 156 closing their positions.
99% less funds holding
Funds holding: 158 → 1 (-157)
100% less capital invested
Capital invested by funds: $2.19B → $3.38M (-$2.19B)
100% less funds holding in top 10
Funds holding in top 10: 8 → 0 (-8)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 156
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$216M |
| 2 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$169M |
| 3 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$130M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$107M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$89.8M |
AUXL Hedge Fund Activity: Q1 2015 in Review
1 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in AUXILIUM PHARAMCEUTICALS INC (AUXL) for Q1 2015, worth a combined $3.38M — down 100% from $2.19B a quarter earlier.
Sellers outnumbered buyers: 156 funds closed out of AUXL and 0 opened new positions — a net loss of 156 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Deerfield Management, exiting entirely with an estimated $216M sold.
- 1 institutional investor held AUXILIUM PHARAMCEUTICALS INC (AUXL) as of Q1 2015, down from 158 in Q4 2014.
- Funds reported $3.38M of AUXILIUM PHARAMCEUTICALS INC stock for Q1 2015, down 100% quarter-over-quarter.
- 0 funds opened new AUXILIUM PHARAMCEUTICALS INC positions in Q1 2015 and 156 closed out, a net change of -156 holders.
- The largest AUXILIUM PHARAMCEUTICALS INC seller in Q1 2015 was Deerfield Management, an estimated $216M sold.
Based on aggregated 13F filings for Q1 2015.